Inotiv, Inc. — Director's Dealing 2013

May 17, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2013-05-08

Reporting Person: Downing Philip A (Sen. Dir., Preclinical Srvcs.)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$5.00	2014-12-30	Common Stock (4000)		Direct
Employee Stock Option (right to buy)	$5.09	2018-09-04	Common Stock (4500)		Direct
Employee Stock Option (right to buy)	$1.01	2020-08-15	Common Stock (10000)		Direct
Employee Stock Option (right to buy)	$1.4	2023-01-16	Common Stock (500)		Direct

Footnotes

F1: All of the options are vested and exercisable.

F2: 1,125 of the options vested and became exercisable on September 4, 2010, 2011 and 2012 and 1,125 of the options vest and become exercisable on September 4, 2013.

F3: 2,500 of the options vested and became exercisable on August 16, 2012 and 7,500 of the options vest and become exercisable in three equal annual installments beginning on August 16, 2013.

F4: The options vest in two equal annual installments beginning on January 16, 2014.